Literature DB >> 10844881

Clinical management of glaucoma.

A King1, C Migdal.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10844881      PMCID： PMC1297972          DOI： 10.1177/014107680009300405

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.

Authors:  Leon C Ho; Ian P Conner; Chi-Wai Do; Seong-Gi Kim; Ed X Wu; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-24       Impact factor: 4.799

2.  In vivo biocompatibility assessment of (PTFE-PVDF-PP) terpolymer-based membrane with potential application for glaucoma treatment.

Authors:  Rafał Leszczynski; Ewa Stodolak; Jarosław Wieczorek; Jolanta Orlowska-Heitzman; Teresa Gumula; Stanislaw Blazewicz
Journal:  J Mater Sci Mater Med       Date:  2010-07-23       Impact factor: 3.896

3.  Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%).

Authors:  Moataz E Gheith; Jason R Mayer; Ghada A Siam; Daniela S Monteiro de Barros; Tricia L Thomas; L Jay Katz
Journal:  Clin Ophthalmol       Date:  2008-03

4.  [Assessment of the use of retinography as a screening method for the early diagnosis of chronic glaucoma in Primary Care: Validation for screening in populations with open-angle glaucoma risk factors].

Authors:  Soraya Sánchez González; José Calvo Lozano; Jessica Sánchez González; Miguel Pedregal González; Manuel Cornejo Castillo; Eduardo Molina Fernández; Francisco Javier Barral; José Ramón Pérez Espinosa
Journal:  Aten Primaria       Date:  2017-01-23       Impact factor: 1.137

5.  Feeling the pressure: a cross-sectional study exploring feasibility of a healthcare Pop-Up for intraocular pressure measurements in shopping centres in England.

Authors:  Laura A Edwards; Deanna J Taylor; Peter Campbell; Rakhee Shah; David F Edgar; David P Crabb
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.